Merck & Co., Inc. is a global research-driven pharmaceutical products company. Committed to bringing out the best in medicine
Contact usWorldwide
HomeAbout MerckProductsNewsroomInvestor InformationCareersResearchLicensingThe Merck Manuals

The Merck Manual--Second Home Edition logo
 
click here to go to the Index click here to go to the Table of Contents click here to go to the search page click here for purchasing information
Chapter 28. Heart Valve Disorders
Topics: Introduction | Mitral Regurgitation | Mitral Valve Prolapse | Mitral Stenosis | Aortic Regurgitation | Aortic Stenosis | Tricuspid Regurgitation | Tricuspid Stenosis | Pulmonary Stenosis
 
green line

Mitral Valve Prolapse

Mitral valve prolapse is a disorder in which the valve cusps bulge into the left atrium when the left ventricle contracts, sometimes allowing leakage (regurgitation) of small amounts of blood into the atrium.

About 2 to 5% of people have mitral valve prolapse. It rarely causes serious heart problems.

Symptoms and Diagnosis

Most people with mitral valve prolapse have no symptoms. Others have symptoms that are difficult to explain on the basis of the mechanical problem alone; these symptoms include chest pain, a rapid pulse, palpitations (awareness of heartbeats), migraine headaches, fatigue, and dizziness. In some people, blood pressure may fall below normal when they stand up (a disorder called orthostatic hypotension).

Doctors diagnose mitral valve prolapse after hearing the characteristic clicking sound through a stethoscope. Regurgitation is diagnosed if a murmur is heard when the left ventricle contracts. Echocardiography (see Section 3, Chapter 21) enables doctors to view the prolapse and determine the severity of regurgitation if present.

Treatment

Most people with mitral valve prolapse do not need treatment. If the heart is beating too fast, a beta-blocker may be taken to slow the heart rate and to reduce palpitations and other symptoms.

If regurgitation is also present, antibiotics should be taken before surgical, dental, or medical procedures (see Section 3, Chapter 29) because bacterial infection of the heart valve (infective endocarditis) is a risk, although a small one.

Site MapPrivacy PolicyTerms of UseCopyright 1995-2004 Merck & Co., Inc.